免疫型MHC-I分析和免疫性测试确定Tcj2是查加斯病mRNA疫苗的新候选者
Leroy Versteeg1,2, Rakesh Adhikari1, Gonteria Robinson1
1Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
研究人员确定Tcj2为查加斯病的有希望的疫苗候选人. 用Tcj2免疫小鼠产生了强烈的免疫反应,减少了寄生虫的复制,并显示了针对慢性查加斯性心肌病的新型mRNA疫苗的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 查加斯病是由Trypanosoma cruzi引起的,在全球范围内影响着数百万人,其中20-30%的人患有慢性查加斯性心肌病 (CCC).
- 目前还没有批准的疫苗用于预防或治疗CCC.
- 有效的疫苗需要刺激CD8+细胞毒性T细胞通过MHC-I呈现的抗原来消除感染细胞.
研究的目的:
- 使用免疫类药物识别Trypanosoma cruzi在感染细胞的MHC-I分子上呈现的抗原.
- 评估已识别的抗原作为查加斯病疫苗候选者的潜力.
主要方法:
- 基于质谱的免疫组学被用来分析T. cruzi感染细胞的MHC-I上呈现的.
- Tcj2,一个试酶的伴侣蛋白质,被确定为多个MHC-I呈现的来源.
- 在小鼠模型中,TCJ2作为mRNA疫苗候选人进行了测试.
主要成果:
- 免疫学发现了许多T. cruzi,其中六个来自Tcj2蛋白.
- 在小鼠中接种Tcj2mRNA疫苗诱导了强大的记忆CD8+T细胞反应和Th1-偏向抗体反应.
- 实验室研究显示,Tcj2接种的小鼠与细胞共培养的感染细胞中的Tc cruzi复制减少.
- 接种Tcj2疫苗的小鼠的抗体缺乏与人类和小鼠DnaJ的交叉反应,这表明自身免疫风险较低.
结论:
- 免疫类药物是发现夏加斯病新型疫苗点的宝贵工具.
- Tcj2是针对CCC的mRNA疫苗的一个有希望的候选抗原.
- 接种Tcj2疫苗引起了对T. cruzi感染的保护性免疫力,具有良好的安全性.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
07:59A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cell-mediated Immune Responses
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
